In Brief: SmithKline Beecham's Havrix
Executive Summary
SmithKline Beecham's Havrix: New pediatric 720EL.U./.5 mL dose introduced at $22.76 wholesale acquisition cost. Merck's Vaqta, approved March 29, will be introduced at a catalog price of $22.86...